Literature DB >> 20186102

External auditory canal and middle ear relapse of acute promyelocytic leukemia treated with arsenic trioxide: case report and review of the literature.

Thereza Christina Sampaio Lafayette1, Virginia Maria Coser, Alice Odette Brûlé, Pedro Luis Coser, Waldir Veiga Pereira.   

Abstract

Extramedullary involvement occurs infrequently in acute promyelocytic leukemia and is said to be more common after treatment with all-trans retinoic acid. We describe a 9-year-old girl who had an isolated external auditory canal and middle ear relapse after treatment with all-trans retinoic acid and chemotherapy. A patient with cytogenetically and molecularly confirmed acute promyelocytic leukemia developed isolated extramedullary relapse in the auditory canal and middle ear 4 years and 9 months after initial diagnosis, while in hematologic and molecular remission, successfully treated with arsenic trioxide alone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186102     DOI: 10.1097/MPH.0b013e3181cf7ef3

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.

Authors:  Yang Wang; Yudan Wei; Haiying Zhang; Yanfen Shi; Yulin Li; Ronggui Li
Journal:  Med Oncol       Date:  2011-02-10       Impact factor: 3.064

2.  Leptomeningeal Relapse of Acute Promyelocytic Leukemia.

Authors:  Tarik Hadid; Salman Fazal; John Lister
Journal:  World J Oncol       Date:  2014-05-06

3.  A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain.

Authors:  Filomena Nozza; Gabriella Vona; Stefania Trino; Fiorella D'Auria; Francesco La Rocca; Vitina Grieco; Luciana Possidente; Luciana De Luca; Pellegrino Musto
Journal:  Mol Cytogenet       Date:  2019-07-05       Impact factor: 2.009

4.  Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells.

Authors:  Yanfei Jia; Dezhi Liu; Dongjie Xiao; Xiaoli Ma; Shuyi Han; Yan Zheng; Shanhui Sun; Maoxiu Zhang; Hongmei Gao; Xia Cui; Yunshan Wang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.